NOX 5.71% 7.4¢ noxopharm limited

Ann: IONIC Trial Abstract Published at ASCO, page-19

  1. 357 Posts.
    lightbulb Created with Sketch. 37
    Hi Dee,

    To me the most important part is this announcement is " complete response (CR) in 2 pts, both with ongoing CR at 24 weeks "

    No cancer for 24 months which shows long term remission, I suppose we will need to wait till next week to find out which of the cancers responded so well to this combination.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.